# EDGAR Filing Document

**Accession Number:** 0001787740
**File Stem:** 0000000000-25-007241
**Filing Date:** 2025-7
**Character Count:** 4145
**Document Hash:** 9c8ac774c76aed0fc49b55b8eb289209
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-25-007241.hdr.sgml**: 20250918

**ACCESSION NUMBER**: 0000000000-25-007241

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250709

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Tivic Health Systems, Inc.
- **CENTRAL INDEX KEY:** 0001787740
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 814016391
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 377-08017

**BUSINESS ADDRESS:**
- **STREET 1:** 47685 LAKEVIEW BLVD
- **CITY:** FREMONT
- **STATE:** CA
- **ZIP:** 94538
- **BUSINESS PHONE:** (888)276-6888

**MAIL ADDRESS:**
- **STREET 1:** 47685 LAKEVIEW BLVD
- **CITY:** FREMONT
- **STATE:** CA
- **ZIP:** 94538
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001683168-25-003732

## Text-Extract

```

                                                             July 9, 2025

Jennifer Ernst
Chief Executive Officer
Tivic Health Systems, Inc.
47685 Lakeview Blvd.
Fremont, California 94538

        Re: Tivic Health Systems, Inc.
            Registration Statement on Form S-1
            Response dated June 26, 2025
            File No. 333-287853
Dear Jennifer Ernst:

     We have reviewed your response letter dated June 26, 2025 and have the
following
comment.

        Please respond to this letter by amending your registration statement
and providing
the requested information. If you do not believe a comment applies to your
facts and
circumstances or do not believe an amendment is appropriate, please tell us why
in your
response.

       After reviewing any amendment to your registration statement and the
information
you provide in response to this letter, we may have additional comments. Unless
we note
otherwise, any references to prior comments are to comments in our June 17,
2025 letter.

Response Letter filed June 26, 2025
Plan of Distribution, page 16

1.     We note your response to previous comment 1 but are unable to agree that
the current
       transaction is consistent with Securities Act Compliance and Disclosure
       Interpretations Question 139.11. Regardless of whether the closing
condition in
       Section 2.3(b)(xiv) was included to address Nasdaq rules related to
future priced
       securities, it is still a closing condition relating to the market price
of the Company's
       securities, which is not permitted by CDI 139.11. Additionally, while
the Selling
       Stockholder may remain obligated to fund the respective tranche if the
trading price
       subsequently exceeds the Floor Price, there is no guarantee that this
will
       occur. Therefore, the Selling Stockholder is not irrevocably bound to
purchase each
       tranche. In addition, the current transaction does not satisfy the
condition discussed in
 July 9, 2025
Page 2

       CDI 139.11 that the closing must occur within a "short time" after
effectiveness, as
       subsequent tranche closings could occur as late as December 31, 2025.
Accordingly,
       you must either revise the registration statement to limit the shares
registered for
       resale to those underlying the already-issued preferred shares and
warrants, or revise
       your prospectus to disclose a fixed price at which the selling
shareholder will offer the
       shares for the duration of the offering and identify the selling
shareholder as an
       underwriter.
      Please contact Conlon Danberg at 202-551-4466 or Katherine Bagley at
202-551-
2545 with any questions.

                                                             Sincerely,

                                                             Division of
Corporation Finance
                                                             Office of
Industrial Applications and
                                                             Services
cc:   Christopher L. Tinen, Esq.

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._